**Core Concept**
Phenobarbitone is a barbiturate that induces the enzymes of the cytochrome P450 system, whereas the other options are either enzyme inhibitors or have other mechanisms of action. This question tests the student's understanding of the effect of various drugs on the enzyme system.

**Why the Correct Answer is Right**
Phenobarbitone is a well-known enzyme inducer, specifically inducing the activity of cytochrome P450 enzymes, including CYP3A4 and CYP2C9. This induction leads to increased metabolism of a wide range of drugs, making phenobarbitone a valuable tool in managing certain types of epilepsy. In contrast, the other options either inhibit enzyme activity or have different mechanisms of action.

**Why Each Wrong Option is Incorrect**
**Option B:** Omeprazole is a proton pump inhibitor (PPI) that inhibits the H+/K+ ATPase enzyme in the gastric parietal cells, thereby reducing gastric acid secretion. It does not induce or inhibit the cytochrome P450 enzymes.
**Option C:** Disulfiram is an alcohol-sensing drug that inhibits aldehyde dehydrogenase, an enzyme involved in the metabolism of ethanol. It does not have any significant effects on the cytochrome P450 system.
**Option D:** Diltiazem is a calcium channel blocker that inhibits the L-type calcium channels in the heart and vascular smooth muscle. While it can be metabolized by the cytochrome P450 system, it does not induce or inhibit the enzyme activity.

**Clinical Pearl / High-Yield Fact**
When managing patients on multiple medications, it's essential to consider the potential for drug interactions due to enzyme induction or inhibition. Phenobarbitone's enzyme-inducing properties can lead to increased metabolism of certain drugs, potentially reducing their efficacy or requiring dose adjustments.

**✓ Correct Answer: A. Phenobarbitone**